hg_131557.1

Basic information about the TSS

---

TSS ID: hg_131557.1 Species: human Chr: chr12		Start: 56636861 End: 56636880 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: LF208948 MA444525 Distance: 15 GeneID: 11176 HGNC/MGI_ID: HGNC:962 UniProt_ID:

Gene_name: BAZ2A Gene_symbol: BAZ2A Gene_synonyms: KIAA0314 TIP5 WALp3 Gene_source: HGNC:962

TATA-Box annotation

---

Distance to TSS:	-512
Nearest PromoterID:	NM_001351156
Entrez ID:	11176
Nearest Unigene:	Hs.314263
Nearest Refseq:	NM_013449
Nearest Ensembl:	ENSG00000076108
Gene Name:	BAZ2A
Gene Alias:	TIP5|WALp3
Gene Description:	bromodomain adjacent to zinc finger domain 2A
Gene Type:	protein-coding
CpG%:	0.02
GC%:	0.58209
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BAZ2A p2@BAZ2A p3@BAZ2A p4@BAZ2A p5@BAZ2A p8@BAZ2A p9@BAZ2A
Sample		p1@BAZ2A	p2@BAZ2A	p3@BAZ2A	p4@BAZ2A	p5@BAZ2A	p8@BAZ2A	p9@BAZ2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	34.68	11.88	1.56	2.34	0.97	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	37.23	8.50	3.03	1.62	0.40	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	35.69	10.80	1.93	2.70	1.35	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	32.43	7.69	2.49	2.29	0.83	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	34.19	8.32	2.92	1.80	0.67	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	31.98	8.72	2.52	1.55	1.16	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	45.76	10.89	3.49	2.18	0.44	0.00	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	39.72	11.63	2.18	3.63	0.97	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	37.61	9.19	1.07	1.92	0.85	0.00	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	37.10	19.13	0.58	2.32	1.16	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	33.55	10.91	2.83	2.02	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	29.68	10.98	2.03	0.81	0.41	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.76	6.77	1.61	0.16	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	20.45	8.42	1.95	0.75	0.60	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	23.93	10.10	1.76	0.66	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.61	6.29	3.27	0.25	1.01	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.22	7.43	0.66	0.44	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	22.78	6.33	4.64	1.69	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.99	9.60	2.67	0.53	1.60	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	19.41	7.97	3.31	0.45	0.45	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	20.85	9.09	1.47	0.94	0.80	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	19.16	8.11	2.42	0.86	0.69	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.93	9.18	2.20	0.78	1.42	0.13	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.50	6.79	0.73	0.73	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	19.61	8.77	2.84	0.00	0.77	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.67	7.91	1.58	0.00	0.00	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	21.98	11.54	3.30	1.65	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.99	8.02	2.59	0.47	0.94	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	17.93	7.59	2.10	0.97	1.13	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.84	6.15	1.81	0.36	0.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.96	5.23	1.88	1.05	0.42	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.98	3.71	0.98	1.17	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	17.52	5.70	2.32	0.42	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	21.11	6.60	0.99	0.99	0.16	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	16.64	4.49	1.68	0.75	0.37	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	16.86	4.22	1.53	0.38	0.96	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	16.96	2.45	1.23	0.41	0.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	16.52	2.82	0.40	1.01	0.60	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	20.26	2.43	0.54	0.54	0.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	24.49	3.60	1.20	0.48	0.96	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	19.53	1.41	1.18	1.18	0.24	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	18.15	2.78	1.90	0.73	0.44	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.62	3.80	0.84	0.21	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	25.70	2.10	1.05	0.35	0.87	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.30	3.81	0.60	1.00	0.60	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	27.22	4.89	0.93	0.23	0.47	0.00	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	23.51	4.08	1.44	0.48	0.24	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	19.97	4.17	2.38	0.30	0.30	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	24.66	3.83	1.91	0.24	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	25.27	3.44	1.21	0.81	0.81	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.05	3.69	7.38	0.82	1.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	26.91	5.11	5.78	0.89	1.33	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	20.23	6.39	4.26	1.06	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	17.56	3.31	4.97	0.66	1.99	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	29.36	13.42	2.52	1.68	7.55	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.96	9.18	7.35	1.84	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.80	4.54	6.48	1.94	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.99	5.46	5.78	0.00	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.46	8.49	7.54	1.57	2.20	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	4.23	3.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.58	7.29	7.29	0.56	0.56	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.85	11.15	9.55	1.59	6.37	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	21.41	9.85	5.10	2.38	2.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	23.72	6.82	5.52	0.97	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.88	11.00	3.19	1.77	1.77	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	15.79	7.90	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.11	20.48	8.29	1.46	2.44	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.87	16.86	4.46	1.49	0.50	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.07	17.83	5.16	0.00	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	17.22	22.85	7.29	0.66	0.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.32	18.25	7.42	3.09	0.93	0.93	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	17.73	16.20	6.42	1.83	0.92	0.00	0.92
Adipocyte - breast, donor1	11376-118A8	5.23	17.42	0.63	0.00	0.48	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	5.78	18.77	1.60	0.16	0.16	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	7.12	21.88	0.38	0.00	0.25	0.13	0.25
Adipocyte - omental, donor2	11474-119C7	1.49	11.21	1.49	0.75	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	4.02	8.71	0.33	1.34	0.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	2.55	8.29	0.64	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	2.20	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.52	8.58	0.00	0.00	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.65	7.82	0.17	0.52	0.00	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	20.34	24.84	1.56	0.59	0.39	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	22.13	18.79	1.54	0.77	0.26	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	15.33	32.90	1.12	0.00	0.00	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	34.09	1.18	1.18	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	17.13	34.34	0.48	0.16	0.56	0.40	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	16.46	17.11	0.00	0.32	0.65	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	10.13	22.93	1.07	1.07	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	7.23	24.48	0.00	0.56	0.56	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	8.32	12.89	0.83	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.07	20.34	0.50	0.25	0.50	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	9.16	23.23	0.98	0.33	0.00	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	11.57	20.10	0.30	0.30	0.00	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	19.67	30.06	0.44	0.00	0.22	0.88	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	8.61	19.00	0.00	0.00	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	9.58	2.40	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.13	27.89	0.18	0.00	0.00	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	21.76	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	12.53	26.30	0.41	0.41	0.00	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	9.50	13.85	0.23	0.69	0.00	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	8.82	7.10	0.49	0.24	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.29	13.93	0.00	0.45	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.08	16.50	0.43	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	14.98	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.77	8.37	1.20	1.20	0.30	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	2.53	0.00	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.96	9.90	0.66	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.17	5.20	0.00	1.30	0.00	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	8.74	0.49	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.13	7.13	1.78	0.59	0.59	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.40	11.68	1.51	1.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	11.61	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	2.51	1.25	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.78	10.87	0.00	0.16	0.00	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1.36	12.28	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.98	6.18	0.00	0.15	0.00	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.18	8.57	1.07	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	7.56	8.31	0.57	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.15	11.23	1.34	0.27	0.27	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	16.58	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.98	9.45	0.33	0.33	0.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	9.61	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	10.62	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.55	10.98	0.00	0.51	0.17	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.85	10.19	0.49	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	8.35	11.38	0.76	0.38	0.76	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	7.27	3.63	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.70	9.69	1.14	1.14	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	3.63	8.98	0.64	0.64	0.00	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.16	8.00	0.52	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.98	11.73	0.94	1.41	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.47	8.04	0.00	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	6.42	1.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.09	7.02	0.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	5.12	12.34	0.60	1.51	0.00	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	5.94	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	10.17	10.68	0.51	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.62	8.15	1.02	1.27	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	6.99	1.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.88	8.20	0.86	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.72	7.41	0.64	0.42	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	3.19	7.25	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	9.45	11.34	0.00	1.89	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	2.71	9.15	0.68	0.51	0.17	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	6.95	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.79	9.22	0.43	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	12.63	1.20	0.00	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	8.02	0.00	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.13	9.88	0.23	0.69	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	7.65	0.00	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.59	8.64	0.25	0.00	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.78	11.77	0.41	0.83	0.21	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.96	8.57	0.61	1.22	0.31	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.08	10.99	1.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.87	7.54	0.67	0.22	0.67	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	6.10	1.53	3.05	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.20	6.65	0.00	0.55	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.53	9.80	0.53	0.00	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.09	5.09	0.73	1.09	0.36	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	11.18	19.77	0.49	0.00	0.12	0.37	0.25
Astrocyte - cerebellum, donor2	11580-120F5	12.84	12.67	0.34	0.34	0.17	0.34	0.34
Astrocyte - cerebellum, donor3	11661-122F5	14.89	13.00	0.42	0.63	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	13.94	12.20	0.35	0.00	0.35	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	21.35	16.34	1.94	0.97	0.16	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	18.35	9.84	1.34	0.15	0.15	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	56.43	36.70	4.01	2.29	1.03	0.34	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	54.50	35.58	3.01	1.50	0.50	0.25	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	48.14	41.54	3.19	1.02	0.57	0.11	0.80
Basophils, donor1	12241-129G9	61.72	31.38	0.52	0.00	0.00	0.26	0.00
Basophils, donor2	12242-129H1	68.91	51.95	1.44	2.16	1.08	2.16	1.08
Basophils, donor3	12243-129H2	58.95	25.28	1.03	0.29	0.59	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	6.68	33.20	0.22	0.43	0.00	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	8.69	12.34	0.00	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	21.52	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	8.16	0.00	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	13.93	13.31	0.42	0.42	0.21	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	7.37	7.37	1.15	0.69	0.23	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	13.86	22.67	1.44	1.08	0.36	0.18	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	55.65	35.97	0.62	0.41	0.10	0.72	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	74.06	45.88	2.33	1.40	0.70	0.47	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.54	7.35	0.64	0.32	0.64	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	69.88	21.42	0.56	1.69	0.00	1.13	0.56
CD14+ Monocytes, donor2	11305-117B9	86.12	31.92	4.64	2.97	0.37	0.56	1.86
CD14+ Monocytes, donor3	11381-118B4	95.28	26.34	2.63	1.10	0.66	0.00	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	30.29	26.04	0.57	0.00	1.98	0.57	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	24.26	26.16	0.38	0.00	1.90	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	34.52	20.71	1.31	0.00	2.30	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	48.13	53.34	6.07	1.01	2.02	0.29	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	35.00	25.65	6.94	0.30	0.91	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	51.88	45.48	3.32	0.47	1.66	0.00	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	35.49	24.27	5.02	0.50	2.01	0.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	26.50	17.11	1.93	0.55	0.83	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	30.25	16.86	1.24	0.25	0.74	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	37.99	21.93	4.31	0.78	0.78	0.00	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	39.17	21.01	3.38	0.53	1.42	0.36	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	25.68	20.89	1.52	0.44	0.00	0.44	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	36.29	18.50	1.40	1.40	0.94	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	36.96	21.12	2.64	0.53	1.06	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	27.73	24.41	0.00	0.00	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	34.51	29.75	5.50	0.45	1.64	0.15	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	20.35	16.56	2.59	0.00	0.80	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	15.61	17.28	0.83	0.21	1.25	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	33.40	24.02	3.20	0.00	1.83	0.23	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	21.26	19.68	1.81	0.00	1.81	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	27.06	16.59	1.31	0.00	3.06	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	59.18	59.45	9.95	2.42	1.88	1.34	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	61.93	48.15	8.03	0.87	2.62	0.35	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	55.13	49.66	7.57	1.26	0.84	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	32.88	14.33	1.84	0.55	1.29	0.18	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	20.08	14.80	2.11	0.35	1.41	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	29.83	14.48	2.19	0.00	0.88	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	42.20	25.11	4.71	0.70	1.39	0.35	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	43.11	30.85	1.86	0.74	0.37	0.74	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	37.29	28.24	2.16	0.65	1.29	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	30.71	19.66	5.73	0.82	2.05	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	17.62	18.54	1.62	0.00	0.00	0.00	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	20.88	12.06	2.32	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	15.26	28.55	0.87	0.22	1.09	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	24.25	38.11	2.31	0.92	1.15	1.15	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	18.20	17.98	0.22	0.43	0.00	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	50.30	47.50	0.93	0.00	0.93	0.47	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	43.49	29.86	1.05	0.70	1.05	0.17	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	75.14	60.20	3.57	0.67	1.34	0.45	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	20.16	46.44	1.02	0.26	0.26	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	20.86	52.48	1.54	0.22	0.00	0.88	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	13.26	38.32	1.05	0.42	0.21	0.84	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	60.97	10.16	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	67.12	16.27	0.00	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	49.71	17.61	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	51.17	26.12	3.20	0.53	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	78.80	22.51	2.14	0.00	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	65.98	21.76	3.51	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	55.69	16.47	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	58.00	9.23	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	225.20	41.92	9.86	12.33	2.47	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	201.67	33.37	7.25	7.98	4.35	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	190.82	32.81	9.59	6.56	2.02	0.50	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	18.18	211.32	0.40	2.02	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	15.18	131.83	0.80	1.60	0.40	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	44.18	18.07	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	42.70	16.29	0.00	0.00	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	24.42	6.39	0.38	0.38	0.38	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	27.96	8.12	0.23	0.23	0.68	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	182.46	40.35	1.43	0.36	0.00	0.71	1.07
CD4+ T Cells, donor2	11306-117C1	136.56	31.84	15.92	4.29	1.84	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	92.41	40.56	6.71	2.13	1.83	1.22	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	36.75	56.15	2.30	0.51	0.77	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	46.72	57.27	0.90	0.67	0.67	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	51.17	55.77	1.44	0.57	1.15	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	64.00	12.33	1.42	0.47	1.42	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	65.32	20.37	0.70	2.81	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	16.48	3.30	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	32.52	47.55	1.30	0.43	1.01	0.43	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	37.62	50.84	4.24	1.19	1.02	0.17	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	33.21	44.65	3.22	0.48	0.64	0.48	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	29.59	26.45	1.34	0.45	0.45	0.00	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	38.43	24.11	3.14	1.40	0.35	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	62.04	45.32	4.84	0.44	0.44	0.44	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	41.32	52.28	2.53	0.00	2.53	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	44.67	30.54	1.45	0.21	1.25	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	33.75	18.38	3.68	1.00	0.33	0.33	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	67.71	24.20	4.35	0.54	2.72	0.54	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	87.36	18.76	2.14	1.61	1.07	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	91.45	12.55	1.79	3.59	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	39.13	50.81	2.97	0.37	0.93	0.19	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	29.89	34.88	1.08	1.08	0.65	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	36.99	35.10	1.68	0.00	0.84	0.63	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	43.99	19.21	1.01	1.01	1.01	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	52.42	25.13	0.87	0.43	0.87	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	58.40	33.56	3.92	1.31	1.74	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	60.87	31.18	1.48	0.99	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	52.62	21.23	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	13.96	1.40	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	65.91	42.09	2.49	0.83	1.11	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	67.24	46.38	1.72	0.00	0.98	1.47	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	33.88	64.68	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	65.89	36.17	3.22	0.36	1.43	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	73.40	31.85	1.38	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	102.15	51.73	1.64	0.98	0.00	0.98	0.33
CD8+ T Cells, donor2	11307-117C2	94.23	44.30	14.64	6.01	3.00	0.75	1.13
CD8+ T Cells, donor3	11383-118B6	159.07	32.82	5.55	3.79	1.01	1.26	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.30	7.57	0.92	0.69	0.69	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	16.06	7.67	0.48	0.96	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.51	9.30	1.09	0.55	0.27	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	10.51	13.21	0.30	1.80	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	19.68	13.44	0.48	0.96	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	12.28	10.69	1.59	0.23	0.23	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	18.25	9.78	0.65	1.09	0.00	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.85	11.58	1.05	0.53	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	16.89	10.32	1.41	0.47	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.38	8.45	0.91	0.60	0.00	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.11	8.42	2.03	1.16	0.29	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.79	6.39	0.80	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	19.26	21.89	0.88	0.44	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	29.60	22.32	2.28	0.46	0.00	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	30.58	27.60	0.00	1.49	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.25	12.61	1.44	1.08	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.96	8.92	0.29	0.29	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.44	10.37	0.94	0.47	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	20.60	18.38	1.27	1.27	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	18.15	14.15	0.92	0.31	0.00	0.00	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.16	9.30	1.28	1.28	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.06	9.56	0.38	1.91	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	17.73	11.03	0.00	0.00	0.00	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	7.56	0.76	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	61.83	33.72	0.80	3.21	0.00	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	67.15	35.67	2.80	1.40	0.00	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	67.12	40.07	2.00	2.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	23.76	3.66	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	16.30	13.34	0.00	0.49	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	7.89	8.42	0.00	0.00	0.21	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	5.55	9.01	0.69	0.35	0.69	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	2.49	12.08	0.00	0.00	0.00	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	7.74	10.13	0.68	0.68	0.11	0.00	0.34
Chondrocyte - re diff, donor2	11339-117F7	16.11	22.38	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	15.37	19.41	0.00	1.21	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	19.97	17.44	0.92	0.57	0.11	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	15.39	10.26	0.64	0.64	0.00	0.00	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	18.94	13.19	0.88	1.06	0.35	0.35	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	64.28	37.32	2.11	2.48	0.73	0.73	0.73
Corneal Epithelial Cells, donor1	11526-119I5	10.98	21.08	0.66	0.00	0.22	0.66	0.22
Corneal Epithelial Cells, donor2	11606-120I4	7.96	35.27	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	15.59	16.87	0.26	0.00	0.00	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.53	31.70	0.00	0.00	0.50	0.83	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.35	23.34	0.32	0.00	0.32	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	34.51	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.96	24.73	1.62	0.97	0.11	0.32	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	32.11	108.30	0.34	0.68	0.34	2.39	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	18.28	87.48	1.31	1.31	0.00	1.96	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	18.87	100.18	0.97	0.97	0.00	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	17.01	15.68	0.17	0.17	0.17	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	9.98	9.98	0.00	0.00	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	16.69	21.49	0.85	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	16.91	11.40	0.39	0.00	0.79	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	14.54	18.91	0.29	0.00	0.58	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	28.23	15.53	4.71	0.71	0.71	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	18.41	12.97	0.18	0.53	0.18	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	17.95	19.51	0.66	0.22	0.22	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.04	30.43	1.52	0.30	0.30	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	21.99	26.22	0.28	0.00	0.28	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	10.40	22.58	0.00	0.00	1.49	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	8.33	18.74	0.52	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	20.84	13.90	0.71	0.43	0.28	0.14	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	19.61	23.21	0.80	0.80	1.20	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	14.68	13.63	2.62	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	36.03	24.73	0.50	1.49	0.75	0.37	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	36.28	14.34	2.17	1.74	0.00	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	44.94	20.27	1.10	1.59	0.24	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	15.93	5.69	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.87	12.57	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.43	8.95	0.16	0.31	0.16	0.16	0.16
Eosinophils, donor1	12244-129H3	15.25	60.99	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	354.81	179.88	6.60	1.65	4.95	3.30	0.00
Eosinophils, donor3	12246-129H5	296.05	128.41	3.57	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.73	28.83	0.49	0.73	0.00	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	16.64	0.00	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	48.81	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	8.21	14.78	1.64	0.00	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.28	5.26	0.77	0.11	0.00	0.33	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.88	5.96	1.19	1.08	0.33	0.00	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	7.28	15.04	0.24	0.36	0.00	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	13.51	65.92	0.41	0.27	0.41	0.82	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	6.54	10.86	0.74	0.00	0.11	0.21	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.02	39.52	1.05	0.53	1.05	0.79	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.62	16.94	0.66	0.66	0.66	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	7.26	5.90	0.00	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.82	15.16	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	10.09	12.30	0.32	0.63	0.16	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	17.58	27.89	0.00	0.00	0.00	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	10.03	11.29	1.27	1.02	0.38	0.00	0.25
Fibroblast - Cardiac, donor6	11460-119B2	13.49	14.25	0.30	0.76	0.30	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	11.12	30.42	0.40	0.13	0.13	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	14.67	12.08	0.86	1.29	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	21.97	16.11	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	23.29	18.45	1.15	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	11.53	30.02	0.68	0.68	0.17	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	12.91	10.33	0.23	0.47	0.23	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	6.13	9.43	0.47	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.48	9.07	0.36	0.73	0.00	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	10.85	7.80	0.90	0.45	0.23	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	13.78	9.59	1.05	0.87	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	11.53	13.64	0.49	0.49	0.16	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	12.49	21.24	0.42	0.42	0.42	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	11.00	27.51	0.26	0.52	0.26	0.52	0.52
Fibroblast - Gingival, donor2	11318-117D4	13.31	20.29	1.45	0.92	0.00	0.13	0.26
Fibroblast - Gingival, donor3	11394-118C8	17.79	22.82	0.58	0.29	0.29	0.19	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	21.82	14.54	0.00	0.00	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.86	10.40	1.59	0.53	1.06	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	17.77	18.08	0.62	0.62	0.62	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	9.60	20.28	0.54	0.27	0.54	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.64	23.64	0.00	0.00	0.71	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	12.28	17.84	0.29	0.73	0.29	0.44	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	10.50	23.59	0.95	0.00	0.68	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.59	14.15	0.55	0.66	0.22	0.22	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.06	25.39	1.03	0.15	0.88	0.59	0.44
Fibroblast - Lung, donor1	11270-116H1	8.16	12.23	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	16.41	0.00	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	13.72	13.72	0.42	0.84	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	16.66	50.81	0.00	0.00	0.00	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	6.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.72	8.68	0.00	0.00	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	30.04	39.78	0.41	0.00	0.41	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	13.19	21.92	0.39	0.19	0.00	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	24.27	20.78	3.03	1.37	0.46	0.46	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.31	32.43	0.00	0.00	0.00	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.78	14.50	0.00	0.00	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	8.10	12.96	0.81	0.54	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.80	9.86	1.04	0.23	0.23	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7.18	8.18	0.22	0.00	0.11	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	34.34	61.16	0.41	0.41	0.61	1.02	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	20.71	0.00	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.91	13.05	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	18.26	56.36	1.39	0.60	0.40	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	7.46	12.61	0.18	0.18	0.36	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	11.43	19.51	0.20	0.00	0.20	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.53	44.83	0.60	0.30	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.23	19.97	1.73	0.43	0.11	0.22	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	11.39	55.68	1.01	0.76	0.51	1.27	0.00
Fibroblast - skin normal, donor1	11553-120C5	6.89	21.49	0.33	0.16	0.33	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.05	61.76	1.00	0.20	0.00	0.60	0.40
Fibroblast - skin normal, donor2	11561-120D4	7.33	21.10	0.80	0.10	0.10	0.50	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	15.72	69.21	2.42	0.30	0.60	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.69	20.79	0.41	0.17	0.25	0.00	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	7.86	23.93	0.51	0.17	0.17	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	12.48	54.52	0.99	0.33	0.00	0.99	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	6.92	22.16	0.53	0.00	0.32	0.11	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	6.92	18.72	0.00	0.00	0.17	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.27	16.94	1.57	1.25	0.31	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	21.79	31.38	4.36	0.00	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.67	23.58	0.00	0.00	0.69	0.69	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.67	27.59	1.82	0.00	0.78	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.80	27.08	0.51	0.00	0.77	1.02	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	27.56	4.59	2.30	0.00	2.30	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	32.54	3.83	4.47	1.28	1.91	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	41.36	9.70	3.42	2.00	0.86	0.57	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	62.60	18.48	1.65	1.10	5.79	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	42.01	22.38	4.79	1.60	2.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	54.09	8.92	3.17	0.59	2.58	0.00	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	52.34	13.48	2.91	1.32	6.34	0.00	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	51.21	12.72	1.30	0.65	1.63	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	39.80	7.08	3.10	1.33	1.77	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	44.09	16.53	2.97	1.13	1.13	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	44.21	17.49	2.59	1.11	0.37	0.37	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	33.58	14.77	2.42	0.81	1.07	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	35.06	17.35	1.36	0.62	0.99	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	37.65	15.23	1.25	0.69	0.69	0.28	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	42.49	13.82	3.66	2.03	1.22	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	31.72	19.62	2.97	0.00	1.14	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	31.39	20.06	2.37	1.99	1.12	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	53.77	20.98	1.31	1.53	0.66	0.00	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.14	21.27	2.66	1.48	0.30	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.63	22.10	2.23	2.23	0.32	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	45.35	22.12	1.79	0.89	0.67	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	30.45	20.16	4.23	1.61	0.81	0.60	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.69	24.09	0.85	0.85	0.68	0.68	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	44.16	34.40	3.10	0.18	1.42	0.53	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	43.29	43.50	2.50	0.10	1.14	0.42	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.08	43.21	1.20	0.00	0.68	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	34.86	25.23	1.44	0.44	0.89	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.02	26.21	1.16	0.17	0.83	0.33	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.36	29.61	1.23	0.00	1.43	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	34.87	26.82	0.62	1.24	1.03	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.24	27.90	1.61	0.81	0.35	0.35	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	31.69	21.01	1.50	1.00	1.83	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	28.44	27.11	2.42	0.88	0.44	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	32.84	34.68	1.35	1.72	0.98	0.86	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.72	26.42	0.65	0.32	0.81	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	38.17	29.19	1.60	1.28	1.92	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	26.34	21.79	0.57	0.38	0.38	0.09	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	33.69	18.19	0.79	0.95	0.47	0.63	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	23.72	28.28	3.04	0.91	1.22	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	25.61	27.91	0.73	0.73	0.31	0.21	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	31.18	23.05	0.22	0.22	0.44	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	22.72	33.67	1.68	0.56	0.28	0.84	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	20.28	28.79	1.20	0.09	0.46	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	22.73	24.33	1.60	1.34	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	22.64	22.64	0.92	0.77	0.31	0.31	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	17.49	20.47	0.91	0.65	0.52	0.13	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.40	19.79	0.27	0.27	0.00	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	20.46	25.99	0.92	1.29	0.37	0.18	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.76	29.61	1.97	1.10	0.66	1.32	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	49.59	57.52	0.00	0.99	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.26	29.15	1.19	0.66	0.26	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.74	29.46	1.41	1.01	0.81	1.01	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	58.97	101.16	1.02	0.25	0.51	1.78	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	33.84	15.13	2.59	1.19	1.39	0.60	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	36.82	10.17	1.08	0.77	0.92	0.31	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	45.83	11.05	0.82	0.82	0.61	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	26.29	5.32	0.63	0.94	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	18.08	5.65	0.28	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.68	8.30	1.38	2.31	1.38	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	39.60	9.90	0.00	2.47	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	28.62	7.74	3.09	2.32	0.77	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	11.23	0.00	3.21	0.00	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	3.48	1.74	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.01	6.51	2.60	1.63	0.98	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	40.36	8.65	3.71	1.65	0.82	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	13.33	0.00	6.66	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	27.41	9.23	2.24	1.68	0.56	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	29.42	7.52	1.96	1.96	1.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	47.81	10.90	0.84	3.36	2.52	0.84	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	37.21	13.04	1.91	1.59	2.23	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	41.78	10.87	3.74	1.36	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	6.26	0.00	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	35.51	16.04	2.86	5.73	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	33.74	15.69	2.66	2.07	0.89	0.00	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	33.88	8.47	1.69	3.39	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	30.65	14.91	3.31	3.31	0.83	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	44.41	11.28	2.99	2.07	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	5.27	0.00	5.27	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	27.68	8.84	1.54	2.69	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.75	12.71	2.28	1.63	0.65	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	19.40	9.36	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	35.44	15.03	3.08	2.31	1.93	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.29	7.53	1.71	1.71	1.03	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	14.91	0.00	2.48	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	43.41	21.71	1.89	5.66	0.94	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	45.26	9.05	7.85	4.83	1.21	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	32.56	17.80	1.02	2.03	1.02	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	39.49	13.16	6.38	1.60	1.60	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	40.95	23.68	3.95	2.96	1.48	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	38.95	21.25	7.08	11.80	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	26.26	13.42	4.08	4.67	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.45	22.82	4.83	2.63	0.88	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	29.67	16.95	2.54	3.39	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	26.26	11.34	1.79	3.58	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	19.90	7.76	0.97	5.34	0.97	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	12.55	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.06	18.71	0.83	0.42	0.42	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	17.99	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.83	19.98	1.59	0.32	0.00	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	1.67	8.35	0.42	0.84	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	16.59	5.34	1.28	0.46	0.23	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.36	4.39	1.01	0.51	0.17	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	13.88	2.28	0.23	0.23	0.00	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.74	4.48	1.31	1.20	0.66	0.22	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.89	4.08	1.07	0.64	0.21	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	15.93	6.46	1.08	0.22	0.00	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.68	6.35	0.50	0.37	0.37	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.35	6.18	0.86	0.69	0.34	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.61	3.84	0.32	0.96	0.96	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	19.59	15.67	1.12	0.00	0.56	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	18.61	15.15	0.43	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	21.15	5.29	0.00	0.00	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	21.52	15.52	0.35	0.35	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.90	19.62	0.00	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.71	10.32	1.05	0.35	0.52	0.52	0.52
Hepatocyte, donor1	11523-119I2	15.74	27.84	1.21	1.21	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	28.01	14.01	0.00	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	19.63	17.79	0.61	0.61	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	27.41	18.93	4.57	3.26	0.65	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	29.19	44.39	2.80	1.22	0.87	0.70	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.43	13.86	0.14	0.14	0.27	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	28.66	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	13.35	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	26.30	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	17.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	23.74	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	25.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	18.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	32.49	22.74	6.50	1.62	1.62	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	25.01	16.67	1.67	0.00	0.00	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	14.52	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	34.41	1.32	2.65	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	21.06	15.52	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	20.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	25.19	20.79	1.26	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	24.75	15.47	0.00	0.00	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	27.78	26.49	2.58	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	35.42	24.15	1.61	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	35.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	32.60	27.71	2.44	2.44	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	30.23	29.39	0.84	0.42	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.09	24.91	2.41	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	17.54	1.85	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	22.19	16.52	0.94	0.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.95	14.51	0.00	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	24.75	25.83	1.08	2.15	0.00	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	29.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	20.41	35.07	1.91	0.64	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	21.87	1.82	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	25.71	37.13	2.86	3.57	0.00	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	33.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.83	23.15	0.93	0.93	0.62	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	26.34	35.12	1.76	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	25.15	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.95	20.86	2.09	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	35.41	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	16.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	25.29	33.13	3.49	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	20.25	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	17.42	0.00	3.48	0.00	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	26.67	27.74	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	15.24	1.39	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	25.65	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	27.61	26.69	0.92	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	21.18	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	18.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	20.09	24.32	1.06	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	10.85	55.16	1.71	0.33	0.98	1.31	0.33
Keratinocyte - epidermal, donor2	11349-117G8	5.86	8.20	0.00	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	18.36	20.07	0.85	0.47	0.38	0.28	0.66
Keratinocyte - oral, donor1	11251-116E9	20.43	39.73	1.36	0.45	0.34	0.57	0.68
Keratocytes, donor1	11527-119I6	24.41	36.10	0.00	0.34	0.34	1.03	0.00
Keratocytes, donor2	11607-120I5	5.86	18.75	1.17	0.00	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	23.32	14.42	1.38	0.59	0.59	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	52.75	10.99	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	17.26	7.55	0.00	2.16	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	14.88	18.68	0.23	0.35	0.23	0.46	0.12
Lens Epithelial Cells, donor3	11690-122I7	12.61	18.06	0.30	0.00	0.10	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	19.92	17.79	0.47	1.07	0.24	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	19.26	8.09	0.00	1.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	19.05	14.48	1.73	0.63	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	8.60	2.15	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.06	11.35	1.26	0.95	0.32	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	17.79	9.27	0.75	1.73	0.43	0.00	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.77	11.90	0.41	0.82	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.43	10.11	0.00	1.01	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.58	12.53	1.27	1.83	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	15.82	11.47	0.79	0.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	20.75	9.50	0.19	0.58	0.19	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.40	10.55	0.19	0.00	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	17.77	9.76	0.70	0.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	21.47	10.02	0.72	0.48	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	15.93	10.16	0.27	0.82	0.55	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.40	10.16	0.92	0.62	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.72	9.98	0.00	0.31	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	22.14	15.37	0.73	0.91	0.00	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	21.72	8.56	0.66	0.99	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	17.57	10.54	0.88	0.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	14.69	10.21	1.24	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.61	12.61	0.00	0.97	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	16.70	12.93	0.00	0.54	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	18.17	10.45	0.15	0.76	0.15	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.00	10.89	0.52	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	22.20	12.56	0.84	0.00	0.63	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	16.09	9.32	0.75	1.05	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.26	11.01	0.69	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.63	6.96	1.32	0.56	0.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	16.96	9.33	0.64	1.17	0.21	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.02	9.21	0.97	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	18.19	10.59	0.66	0.66	0.66	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	17.34	12.64	0.62	0.74	0.12	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.88	15.55	0.00	2.96	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.58	7.66	0.00	0.49	0.74	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	13.61	8.66	0.27	0.82	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.44	8.36	1.29	0.00	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	23.74	13.39	0.00	0.91	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	19.18	12.04	0.28	0.42	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	16.36	9.60	0.71	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.51	13.57	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.94	10.27	0.62	0.62	0.16	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	13.25	8.59	0.72	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	19.60	11.76	0.33	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.71	9.42	0.71	0.00	0.24	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	20.67	16.71	0.25	0.99	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	19.72	8.96	0.51	0.26	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	18.50	7.16	0.60	2.39	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	9.06	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	26.08	5.37	0.00	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	6.68	2.23	1.48	0.00	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	23.27	16.93	4.23	1.69	0.85	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	19.69	11.96	0.00	0.00	0.00	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	15.88	14.01	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.10	11.85	8.24	2.06	0.52	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	16.65	13.08	2.38	2.38	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	17.42	14.93	0.45	0.23	0.23	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.12	9.31	5.82	1.45	0.00	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	19.81	8.55	0.45	0.90	0.90	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	26.28	20.05	2.57	0.54	0.95	0.81	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.89	10.27	4.11	0.51	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	19.05	8.12	0.71	0.35	1.06	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	18.66	6.00	0.67	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.41	15.28	5.60	1.02	0.00	0.51	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	20.01	12.54	1.60	0.53	0.53	0.27	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	23.24	14.17	5.86	1.70	1.32	0.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.25	11.04	3.07	1.84	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	27.72	11.42	3.26	0.82	0.00	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	18.53	9.37	4.16	1.25	2.08	0.42	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	18.22	12.61	5.04	0.84	0.84	0.00	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	7.21	0.00	1.03	0.00	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	26.13	11.90	2.61	2.90	0.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	15.54	7.77	3.59	1.20	0.30	0.60	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	24.90	8.30	1.66	0.00	0.55	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	30.40	19.44	3.18	2.83	0.35	0.35	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	18.07	14.75	6.64	1.48	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	8.06	1.15	0.00	0.00	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	25.71	18.04	3.07	1.15	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	22.08	16.42	7.36	0.57	0.57	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	23.79	9.03	3.28	0.00	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	23.95	12.65	6.33	2.26	1.36	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	23.70	18.67	5.75	2.87	1.44	0.00	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.15	11.20	2.24	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	24.90	15.24	8.18	3.34	0.74	0.74	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.35	17.66	3.45	1.29	0.86	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	20.55	11.13	0.86	0.00	0.00	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	25.65	16.99	2.33	0.67	0.00	0.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.93	21.12	3.02	0.00	0.60	1.21	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	20.62	10.66	2.13	0.71	0.00	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	25.78	16.50	6.19	2.75	1.03	1.03	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	27.91	20.93	4.83	2.15	1.61	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	25.59	16.16	3.37	0.67	0.67	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.52	21.85	8.15	1.11	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	26.75	15.12	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	16.92	13.75	2.12	1.06	0.00	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	23.21	20.81	5.20	2.00	2.00	0.00	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	20.35	18.17	2.91	0.00	0.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.76	11.50	0.00	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	22.20	15.29	6.91	2.47	0.00	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	19.76	3.76	0.94	0.00	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	26.15	9.55	2.51	0.00	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	21.63	14.87	4.06	4.51	2.70	0.00	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	8.61	10.33	5.16	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	26.72	15.14	4.01	1.34	0.89	1.34	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	27.76	13.69	3.91	1.17	0.78	0.00	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	15.17	5.28	1.32	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	22.83	15.05	3.11	1.56	0.00	0.00	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	33.69	16.63	7.88	2.19	0.44	1.31	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.72	13.42	3.35	1.12	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.50	11.04	3.53	2.21	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	26.61	17.74	5.79	2.70	0.39	0.00	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	23.80	12.15	3.04	0.51	2.53	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	23.07	12.50	1.44	1.44	0.00	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	24.65	15.50	5.17	3.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	24.91	10.94	1.22	1.82	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.13	12.45	2.77	2.08	1.38	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	26.98	19.38	3.04	2.66	0.38	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.37	16.01	5.16	0.52	1.03	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.37	12.09	1.81	2.42	0.60	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.52	16.80	7.29	1.58	0.95	0.00	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.99	17.06	2.67	1.60	1.07	0.53	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	25.29	10.34	2.30	1.15	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	24.17	28.28	7.20	1.03	1.03	0.51	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	22.64	22.64	6.37	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	23.83	15.89	3.97	1.13	1.13	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	24.55	17.47	2.50	2.08	0.00	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	23.49	20.36	7.83	0.00	0.00	0.78	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.89	7.10	2.51	1.25	0.84	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	30.20	18.12	5.58	1.86	1.86	1.39	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.07	20.07	2.68	0.67	1.34	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.59	19.25	4.28	1.60	0.00	1.60	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	35.96	20.61	4.04	3.64	1.21	0.40	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	24.78	15.60	0.92	0.00	1.84	0.00	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	31.12	16.89	2.67	1.78	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	30.77	23.36	1.71	0.57	3.42	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	17.64	4.60	2.30	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.34	14.23	2.74	1.64	1.09	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	25.39	18.26	6.24	4.01	1.34	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	28.34	33.53	2.08	0.26	0.52	1.56	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.88	15.25	1.33	0.66	1.99	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	16.63	12.47	2.08	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	11.85	23.70	0.23	0.46	0.23	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	6.97	10.09	0.37	0.00	0.18	0.37	0.18
Macrophage - monocyte derived, donor3	11389-118C3	10.49	15.86	0.26	0.26	0.00	0.13	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.19	10.62	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	7.29	30.90	0.95	0.63	0.00	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	7.64	28.21	0.42	0.69	0.42	0.42	0.14
Mammary Epithelial Cell, donor1	11273-116H4	11.66	16.04	0.50	0.10	0.30	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	7.82	19.98	0.00	0.87	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	13.97	11.22	0.50	0.50	0.00	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	49.49	41.35	1.36	0.00	0.68	0.68	0.00
Mast cell, donor1	11563-120D6	44.01	33.74	0.65	0.32	1.41	0.11	0.32
Mast cell, donor2	11565-120D8	58.84	58.54	2.08	0.30	2.08	0.00	0.30
Mast cell, donor3	11566-120D9	74.97	65.74	2.03	0.23	1.13	0.45	0.23
Mast cell, donor4	11567-120E1	58.68	59.57	1.24	0.18	1.77	0.53	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	29.50	36.93	1.22	0.33	0.78	0.22	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	26.27	29.77	1.75	0.58	2.33	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	19.62	28.68	0.92	0.34	1.49	0.00	0.34
Mast cell, expanded, donor8	11941-126A6	42.18	53.06	1.51	0.00	2.68	0.33	0.50
Melanocyte - dark, donor1	11502-119F8	19.60	13.73	0.00	0.30	0.30	0.30	0.50
Melanocyte - dark, donor2	11582-120F7	14.19	9.00	0.69	0.69	0.00	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	20.14	22.02	0.29	0.36	0.00	0.29	0.14
Melanocyte - light, donor1	11274-116H5	16.69	25.86	0.47	0.71	0.47	0.24	0.47
Melanocyte - light, donor2	11351-117H1	15.01	17.06	0.00	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	8.67	1.73	0.00	1.73	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	14.06	14.68	0.52	0.52	0.10	0.31	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	19.90	21.25	0.27	0.54	0.27	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	29.73	27.05	0.80	1.34	0.80	0.54	0.27
Meningeal Cells, donor1	11493-119E8	11.66	38.58	0.50	0.00	0.12	0.37	0.12
Meningeal Cells, donor2	11573-120E7	16.29	16.29	0.44	0.44	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	10.27	18.42	1.22	0.16	0.00	0.49	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.70	8.55	0.00	0.00	0.00	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.77	13.59	0.40	0.20	0.10	0.30	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	11.83	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	11.77	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.18	7.18	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	7.62	17.79	0.42	0.00	0.21	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.53	17.09	1.51	0.50	0.00	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.87	16.26	0.22	0.00	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.80	10.23	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.46	17.19	0.20	0.20	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	3.74	15.24	0.14	0.00	0.28	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	12.27	20.82	0.74	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	18.03	32.10	0.79	0.79	0.26	0.53	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.28	24.93	0.59	0.59	0.00	0.59	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	21.02	4.67	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	18.57	16.65	0.00	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	7.80	8.15	0.00	0.35	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.14	15.32	0.63	0.31	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.26	3.63	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	6.10	13.52	0.27	0.53	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	7.01	8.01	1.00	0.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	10.12	16.12	0.87	0.29	0.22	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	28.36	14.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.08	12.07	0.74	0.74	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.02	12.07	0.00	0.00	0.00	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	7.75	8.99	0.31	0.00	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.85	7.88	0.00	0.00	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	13.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	9.76	16.02	1.25	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.15	18.15	0.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	8.54	13.01	0.20	0.20	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.50	12.27	0.79	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	3.54	11.50	0.88	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.22	10.64	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	11.84	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.94	11.46	1.49	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	8.29	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.54	10.43	0.60	0.60	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	10.06	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	9.03	9.03	0.75	0.25	2.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.93	14.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.82	7.19	0.00	0.00	0.00	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	9.67	16.12	1.84	0.00	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.25	15.35	0.00	0.63	0.00	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.43	17.73	1.22	0.00	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.44	11.59	0.21	0.43	0.43	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	23.34	17.78	0.22	0.44	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.48	13.80	0.44	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	23.32	20.79	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	31.48	6.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.94	16.31	2.17	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.88	24.41	0.59	0.29	0.00	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	6.54	0.00	0.00	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.26	8.65	0.48	0.96	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.01	21.21	0.80	0.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	28.80	5.48	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.02	8.51	1.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	30.58	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	23.65	8.76	1.75	0.88	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	29.80	13.24	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	39.70	7.68	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	28.01	13.88	0.99	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	25.05	8.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	46.41	15.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.98	15.04	0.68	0.00	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	29.32	13.13	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	36.57	10.65	0.00	0.36	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	16.55	13.47	1.12	0.00	0.28	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.70	13.30	1.66	0.83	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	39.63	18.07	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.17	13.27	1.21	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	18.78	18.37	2.09	0.00	0.42	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.94	6.46	0.92	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	26.75	19.92	0.00	0.57	0.57	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	35.24	22.52	1.11	0.14	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	21.77	13.48	1.81	0.26	0.00	0.26	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	24.88	19.73	0.43	1.29	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	31.12	11.43	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	31.49	22.42	0.80	0.00	0.53	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	27.24	14.37	0.30	0.00	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.44	14.83	0.99	0.42	0.00	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	18.79	16.24	2.23	0.64	1.27	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	25.43	25.21	1.11	1.11	0.44	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	35.64	15.17	0.00	0.00	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	24.72	22.16	0.28	1.14	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.04	15.24	1.97	0.25	0.49	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	32.58	14.34	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.05	18.82	1.76	0.59	0.29	1.18	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	28.54	13.26	1.15	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.08	28.85	0.82	0.00	0.82	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.46	22.04	0.60	0.89	0.60	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	15.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	3.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	10.19	14.46	0.99	0.33	0.00	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	11.57	1.05	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.52	12.85	0.79	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	4.66	12.11	0.93	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	8.64	7.14	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.46	6.13	0.27	0.27	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	3.73	10.41	0.11	0.11	0.23	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.74	11.05	2.21	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.16	14.66	0.00	0.00	0.00	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	12.44	0.00	0.00	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.07	2.14	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	8.08	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.48	3.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	4.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.72	2.54	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	1.51	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	17.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	19.57	0.00	0.00	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	50.20	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	2.15	22.62	0.43	0.43	0.43	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	5.75	12.54	1.05	0.00	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.68	16.02	0.67	1.33	0.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.60	9.60	0.83	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	14.64	23.20	1.52	0.76	0.38	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	17.55	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	8.84	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	9.19	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.19	5.44	0.84	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.53	13.48	0.46	0.23	0.00	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.32	9.73	0.27	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	14.72	14.51	0.63	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	22.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	10.92	0.99	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.10	9.47	1.35	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.57	9.07	0.68	0.45	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.19	7.19	0.16	0.98	0.33	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.85	11.30	0.91	1.09	0.00	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.37	9.55	1.06	0.00	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.20	9.00	0.00	0.60	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.32	18.05	2.30	3.28	0.98	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.94	7.16	0.33	0.33	0.16	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.11	18.87	0.71	0.71	0.18	0.18	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	13.36	4.22	0.70	1.41	1.41	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	7.36	5.98	1.84	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.64	5.46	0.64	0.32	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.83	18.97	1.38	2.07	1.03	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	73.32	20.23	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.72	10.92	0.67	0.22	0.00	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.82	6.77	1.69	1.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.10	12.10	1.42	0.71	0.47	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.87	5.58	0.43	0.43	0.43	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.66	6.66	0.00	0.67	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.54	12.17	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.95	7.54	0.40	0.00	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	6.50	0.93	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	7.95	8.70	1.14	1.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.38	8.47	0.98	0.65	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.25	15.69	0.00	0.44	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.45	18.09	0.00	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	5.29	1.76	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	8.64	6.65	0.66	1.99	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.41	8.93	0.50	0.50	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	10.34	11.10	0.00	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.80	15.42	0.60	0.60	0.30	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	14.81	12.16	0.00	0.22	0.22	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.84	12.20	0.00	0.68	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.71	3.66	0.00	0.61	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.79	12.59	0.63	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.59	14.53	0.00	0.91	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	12.66	0.00	0.79	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	23.81	2.27	1.13	3.40	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	7.83	16.27	0.37	0.50	0.00	0.12	0.12
Myoblast, donor2	11322-117D8	10.55	19.37	2.30	1.15	0.38	0.19	0.19
Myoblast, donor3	11398-118D3	11.94	12.78	0.17	0.17	0.00	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	25.98	20.87	0.44	0.15	0.29	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	102.40	47.67	1.23	0.62	0.62	0.62	0.31
Natural Killer Cells, donor2	11311-117C6	94.09	35.28	10.55	3.32	0.90	1.21	0.60
Natural Killer Cells, donor3	11387-118C1	113.75	35.71	3.31	2.76	0.55	0.18	1.10
Neural stem cells, donor1	11275-116H6	31.21	33.03	5.81	0.00	1.81	0.00	1.09
Neural stem cells, donor2	11352-117H2	36.59	19.26	0.00	1.93	3.85	0.00	0.00
Neurons, donor1	11494-119E9	27.31	19.34	1.14	1.14	0.00	0.00	1.14
Neurons, donor2	11574-120E8	22.02	9.03	0.88	0.22	0.22	0.00	0.22
Neurons, donor3	11655-122E8	27.13	12.33	0.82	3.29	0.82	0.82	0.00
Neutrophils, donor1	11233-116C9	183.74	155.90	8.35	4.64	5.57	0.93	4.64
Neutrophils, donor2	11314-117C9	168.13	78.27	52.18	17.39	8.70	2.90	14.49
Neutrophils, donor3	11390-118C4	297.48	205.85	6.11	3.05	12.22	3.67	3.67
Nucleus Pulposus Cell, donor1	11252-116F1	14.37	18.64	0.12	0.83	0.12	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	14.65	14.00	0.00	0.33	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	6.42	5.62	0.40	0.00	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	11.43	19.00	1.79	0.96	0.14	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	7.53	17.37	4.49	2.17	0.58	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	8.97	19.18	1.25	0.23	0.23	0.34	0.34
Olfactory epithelial cells, donor4	11936-126A1	18.21	21.62	0.68	0.97	0.29	0.39	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	18.66	27.68	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	2.55	10.42	0.21	0.00	0.43	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	10.29	1.14	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	3.10	0.00	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	6.25	6.84	0.39	0.00	0.20	0.20	0.00
Osteoblast, donor2	11354-117H4	8.43	13.34	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	5.87	9.60	0.18	0.00	0.53	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	8.93	23.50	0.51	0.76	0.42	0.42	0.42
Pericytes, donor1	11491-119E6	7.68	22.92	0.11	0.11	0.45	0.22	0.22
Pericytes, donor2	11571-120E5	14.49	11.77	0.00	0.68	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	12.61	15.06	0.81	0.20	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	14.35	18.87	0.00	0.11	0.00	0.00	0.00
Perineurial Cells, donor2	11579-120F4	20.43	18.22	0.37	0.18	0.37	0.28	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	136.42	61.52	2.23	0.64	0.96	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	94.76	45.79	10.04	6.12	0.98	0.24	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	98.36	34.30	3.36	2.20	1.04	0.52	0.52
Placental Epithelial Cells, donor1	11278-116H9	9.33	6.70	0.00	0.00	0.00	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	8.87	11.09	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	13.94	10.21	0.59	0.00	0.00	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.16	7.91	0.63	0.32	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	4.50	13.69	0.19	0.56	0.00	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.79	48.56	0.39	0.00	0.13	0.78	0.26
Preadipocyte - breast, donor2	11328-117E5	6.08	13.51	1.35	0.00	0.45	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	7.03	15.02	0.75	0.32	0.00	0.32	0.00
Preadipocyte - omental, donor2	11329-117E6	7.42	21.82	0.87	0.00	0.44	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	7.88	12.03	0.57	0.14	0.29	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	3.94	4.92	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	8.60	11.67	0.00	0.00	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	13.81	13.28	1.95	0.53	0.53	0.53	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	10.22	7.83	0.51	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	13.97	17.05	0.65	0.28	0.37	0.28	0.37
Preadipocyte - visceral, donor2	11357-117H7	5.98	12.89	1.38	0.00	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	9.40	10.34	0.73	0.10	0.52	0.10	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	17.20	19.01	1.21	1.66	0.91	0.15	1.06
Prostate Epithelial Cells, donor2	11331-117E8	6.23	22.75	2.30	1.08	0.81	1.08	0.27
Prostate Epithelial Cells, donor3	11404-118D9	9.68	21.86	0.86	0.43	0.73	0.18	0.37
Prostate Stromal Cells, donor1	11254-116F3	10.36	14.01	0.34	0.23	0.46	0.11	0.23
Prostate Stromal Cells, donor2	11332-117E9	9.14	11.30	1.79	0.54	0.54	0.18	0.36
Prostate Stromal Cells, donor3	11405-118E1	10.01	9.80	0.52	0.31	0.52	0.10	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	27.01	10.95	0.00	0.36	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.83	19.34	0.62	0.55	0.28	0.14	0.14
Renal Epithelial Cells, donor1	11517-119H5	25.87	17.25	0.00	0.51	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	24.90	19.21	1.42	0.00	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	18.42	21.17	0.21	0.21	0.21	0.11	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.98	12.26	2.04	0.00	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	18.73	14.15	1.89	0.67	0.13	0.00	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.54	14.87	1.78	1.78	0.22	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	7.99	0.67	0.67	0.67	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	21.13	25.53	0.22	0.00	0.44	0.44	0.66
Renal Mesangial Cells, donor2	11598-120H5	29.47	20.69	0.00	2.51	1.88	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	19.97	14.15	0.55	0.55	0.00	0.00	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	17.72	24.43	0.54	0.27	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.07	8.86	0.42	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	23.91	15.62	0.39	0.77	0.19	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.71	8.04	0.26	0.26	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	30.41	9.66	0.57	0.28	0.85	0.00	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	18.52	10.29	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.04	7.28	0.25	0.75	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	32.21	58.40	0.53	0.80	1.34	0.53	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	36.63	1.79	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	19.26	72.65	1.10	1.10	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.14	49.88	2.90	0.58	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	22.36	43.82	1.95	0.13	0.26	0.65	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	31.68	38.33	2.78	1.49	0.60	0.20	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	29.11	53.98	0.56	1.12	0.11	0.45	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	24.93	42.67	1.98	1.36	0.50	0.37	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	29.49	41.61	3.26	1.52	0.70	0.35	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	34.90	50.39	2.77	3.24	0.92	0.92	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	30.39	39.57	0.27	0.82	0.55	0.68	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	33.58	41.15	4.39	1.51	1.66	0.30	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	26.88	36.02	0.36	0.54	0.00	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	24.39	32.13	0.43	1.00	0.00	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	30.58	42.93	2.47	2.15	0.43	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	31.64	32.53	0.89	0.66	0.66	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	29.25	36.71	1.72	0.96	0.19	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	33.26	40.34	1.96	0.56	0.56	0.65	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.99	75.35	0.56	0.38	0.75	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	31.58	31.98	0.40	0.53	0.40	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	35.92	37.18	2.43	1.65	0.68	0.49	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	36.47	40.87	1.91	1.34	0.95	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	29.90	28.73	0.85	0.53	0.11	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	26.07	35.88	3.08	1.68	0.56	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.42	40.50	1.37	1.20	1.37	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	31.91	26.26	0.91	0.18	0.36	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	27.84	35.93	2.82	1.35	0.61	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.13	36.00	0.67	1.07	0.13	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	24.29	29.72	0.71	0.71	0.47	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	30.36	37.70	3.57	0.79	0.20	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	27.59	33.44	0.94	1.40	0.23	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.30	26.13	0.62	1.87	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.67	36.28	9.29	5.31	1.55	0.88	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	35.30	33.00	1.04	0.84	0.21	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.13	34.18	1.62	1.08	0.67	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	39.85	36.95	0.85	0.17	0.34	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	40.87	37.98	0.58	1.54	0.96	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	26.13	40.75	1.55	1.72	0.52	1.20	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	37.72	41.42	1.78	0.82	0.55	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	31.36	56.97	2.30	5.42	0.66	0.33	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	33.23	43.63	1.36	1.02	0.85	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	29.59	39.65	0.74	1.33	0.00	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	34.92	54.38	0.53	1.07	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	33.32	28.76	0.55	0.28	0.41	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	23.33	33.81	0.24	1.43	0.48	0.48	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	48.17	71.55	0.40	2.42	0.60	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.00	32.96	1.51	0.57	1.04	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	23.06	36.68	1.40	2.45	1.75	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	22.36	36.57	0.00	0.60	0.00	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	20.44	30.96	1.10	0.37	1.35	0.12	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	54.87	100.43	0.58	1.31	1.16	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	25.55	45.02	0.00	0.00	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	22.30	28.03	0.60	1.21	0.60	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	26.69	48.18	2.71	0.90	1.13	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.35	56.91	3.00	1.20	0.30	0.60	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.52	39.91	1.18	0.35	6.14	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	20.70	41.41	4.27	0.21	2.56	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	25.84	45.67	3.61	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	11.10	12.79	0.00	1.32	0.38	0.19	0.38
Schwann Cells, donor2	11578-120F3	23.82	6.80	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.33	9.20	0.22	0.88	0.22	0.66	0.00
Sebocyte, donor1	11220-116B5	28.48	55.87	1.10	0.00	0.55	1.10	0.00
Sebocyte, donor2	11301-117B5	16.54	25.74	4.60	0.46	0.46	0.46	0.46
Sebocyte, donor3	11378-118B1	12.78	27.41	0.62	0.21	0.62	0.21	0.41
Sertoli Cells, donor1	11255-116F4	19.88	11.60	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	19.77	5.65	0.00	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	15.48	13.64	0.44	0.18	0.53	0.18	0.18
Skeletal Muscle Cells, donor2	11358-117H8	5.78	3.61	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	7.52	9.20	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	10.53	7.70	0.31	0.47	0.31	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	9.22	6.54	1.04	0.30	0.30	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	14.01	7.54	0.92	0.62	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	11.47	25.58	0.76	0.13	0.25	0.38	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.56	13.70	1.43	1.14	0.57	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	17.96	8.53	1.09	0.30	0.10	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.31	15.08	0.17	0.25	0.08	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	6.51	5.79	0.00	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.54	5.50	0.28	0.00	0.28	0.00	0.00
Skin - palm, donor1	10286-104F7	42.98	34.92	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.50	15.71	1.59	1.15	1.01	0.58	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	18.81	152.13	22.08	5.73	4.09	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.48	15.19	2.47	0.78	0.78	0.26	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	6.95	21.96	0.83	0.42	0.42	0.14	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	10.41	15.89	2.53	0.42	0.98	0.00	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	33.83	108.68	2.33	0.42	0.42	1.27	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	14.54	22.04	0.45	0.97	0.45	0.52	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.25	5.86	0.62	0.31	0.31	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	10.00	31.79	0.44	0.22	0.67	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	10.58	8.23	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.90	25.19	0.66	0.44	0.66	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.09	15.75	0.00	0.00	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.95	6.18	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	28.02	45.03	2.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.59	15.17	0.27	0.13	0.27	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	10.64	9.53	0.44	0.44	0.22	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1.92	4.10	0.38	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	10.09	16.93	0.33	0.00	0.00	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.34	18.01	0.00	0.30	0.00	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.81	11.82	0.14	0.14	0.14	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	9.11	15.45	0.16	0.00	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	12.48	16.74	0.91	0.61	0.61	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	7.07	14.90	0.00	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	18.36	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	7.63	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	10.47	18.73	0.74	0.59	0.00	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	11.62	13.99	1.94	0.86	0.43	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	14.17	12.59	0.63	0.63	0.10	0.10	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.97	16.55	0.00	0.00	0.15	0.46	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	6.47	1.08	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.17	6.28	0.30	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.51	18.44	0.34	0.00	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	15.47	30.08	0.47	0.71	0.00	0.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.46	19.22	1.11	0.10	0.20	0.40	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.25	20.02	1.37	0.91	0.00	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.23	6.04	0.00	1.81	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	24.37	20.93	0.79	0.00	0.00	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	9.32	19.71	0.13	0.27	0.13	0.27	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.52	13.77	1.63	0.13	0.38	0.13	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.31	19.02	0.51	0.00	0.25	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	8.29	19.45	0.15	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	5.25	0.00	1.50	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	69.78	109.84	6.46	6.46	5.17	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	10.23	11.16	0.00	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.09	9.59	0.50	1.01	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.27	11.28	1.25	0.00	0.31	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	8.26	12.39	0.00	0.00	0.00	0.00	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	12.41	11.00	0.08	0.17	0.00	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.41	17.28	0.93	0.47	0.47	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.91	17.70	0.14	0.00	0.00	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.90	11.73	0.00	0.00	0.25	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.26	5.45	0.19	0.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	20.26	15.93	0.84	0.00	0.00	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.71	11.90	0.25	0.00	0.00	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.10	8.57	0.48	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.85	14.19	0.00	0.00	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.51	11.27	0.44	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	5.56	17.85	1.76	0.29	0.00	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.88	17.69	0.97	0.58	0.39	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	6.61	16.93	1.32	0.00	0.00	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	3.35	42.03	3.35	0.00	1.49	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.42	25.51	2.52	0.72	0.00	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.38	17.32	0.57	0.28	0.00	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.91	13.79	0.00	0.39	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.89	17.27	2.03	0.25	0.25	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	10.78	16.77	1.20	0.40	1.20	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	7.52	11.29	1.25	0.42	0.42	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	5.50	13.29	2.29	0.46	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	5.39	13.63	0.00	0.50	0.17	0.17	0.17
Synoviocyte, donor2	11368-117I9	8.55	9.05	0.50	0.00	0.17	0.00	0.00
Synoviocyte, donor3	11440-118H9	7.15	7.82	0.89	0.45	0.22	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	19.65	27.51	0.71	0.36	0.00	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	13.87	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	13.89	13.43	0.23	0.23	0.00	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	10.39	16.85	0.36	0.00	0.29	0.43	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	10.82	10.82	0.00	0.00	0.77	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	5.73	0.00	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.30	54.13	0.98	1.11	1.35	0.49	0.49
Urethra, donor2	10319-105A4	52.15	35.97	5.40	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	15.14	31.08	0.27	0.27	0.00	1.59	0.27
Urothelial Cells, donor2	11600-120H7	12.02	26.04	0.40	0.40	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	11.46	21.09	0.69	0.23	0.46	0.23	0.69
Urothelial cells, donor0	11216-116B1	17.61	30.76	0.22	1.11	0.22	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	36.48	48.94	0.89	0.00	0.89	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	35.74	60.04	1.43	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	68.45	61.61	2.05	3.42	0.68	0.68	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	59.57	52.34	1.38	1.03	0.69	0.34	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	47.64	54.62	0.58	1.16	0.00	1.74	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	32.28	69.76	2.08	1.04	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	37.63	78.93	1.84	0.00	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	68.47	49.30	4.56	2.74	3.65	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	28.74	18.01	0.62	0.86	0.37	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	18.48	7.92	0.00	0.00	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	25.42	29.61	1.68	0.28	0.00	0.56	0.00
achilles tendon, donor2	10292-104G4	31.00	45.46	8.27	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	48.70	32.89	0.76	0.25	0.25	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	42.02	12.31	0.23	0.23	0.23	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	66.36	44.99	1.90	0.36	0.00	0.59	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	36.46	28.57	1.36	0.27	0.27	0.82	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	19.68	5.06	1.12	0.84	0.28	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	24.74	13.53	0.63	0.42	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	49.54	20.96	2.72	0.54	1.09	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	30.40	10.13	0.88	0.00	0.00	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	39.61	19.19	2.45	0.82	0.00	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	49.70	17.86	1.94	0.39	0.00	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	25.21	3.31	1.66	0.55	0.18	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	11.70	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	36.25	7.67	1.86	0.70	0.46	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	41.42	8.54	1.81	1.29	0.78	0.00	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	39.16	5.55	2.92	0.58	0.29	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	44.15	13.01	0.46	0.46	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.26	16.45	2.47	0.41	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	55.56	2.76	1.84	1.53	0.00	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	40.11	8.53	0.85	1.28	0.43	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	47.62	10.62	0.91	0.00	0.30	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	43.81	13.96	0.96	0.48	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	30.52	14.03	2.00	0.22	1.11	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	35.36	15.68	1.33	0.33	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	61.32	24.16	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	22.22	12.43	0.00	0.00	0.00	1.13	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	71.96	21.37	0.87	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	13.12	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	42.39	18.60	0.00	0.47	0.00	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	40.02	32.11	2.02	0.78	4.19	0.00	0.31
adipose, donor1	10184-103D4	62.16	41.05	4.69	4.69	8.21	0.59	0.59
adipose, donor2	10185-103D5	34.87	20.68	2.84	0.81	1.62	0.00	0.81
adipose, donor3	10186-103D6	36.49	24.78	4.36	0.54	1.63	0.54	0.27
adipose, donor4	10187-103D7	49.40	43.34	6.93	2.60	6.07	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	48.92	30.62	0.63	1.10	0.47	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	32.74	14.55	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	55.10	52.43	1.87	0.27	0.40	0.80	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	46.09	33.23	0.36	0.36	0.71	1.07	0.71
amniotic membrane cells, donor1	12235-129G3	7.19	27.59	1.39	0.23	0.23	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	14.20	13.86	0.68	0.00	0.00	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	13.26	32.41	1.18	0.29	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	33.20	9.49	2.37	1.19	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	60.42	24.53	3.04	1.62	0.41	0.00	0.81
amygdala, newborn, donor10223	10360-105E9	22.92	15.82	1.94	1.29	0.65	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	34.00	18.59	0.64	0.38	1.27	0.25	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	41.70	6.40	1.10	0.66	0.22	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	37.75	3.01	1.34	0.67	0.33	0.00	0.33
aorta, adult, pool1	10052-101G7	36.28	47.07	1.77	1.77	0.59	0.20	0.78
appendix, adult	10189-103D9	72.97	42.30	5.05	0.78	1.55	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	36.46	22.01	2.06	1.38	0.34	0.00	0.00
artery, adult	10190-103E1	38.04	24.46	6.79	0.00	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	35.20	35.78	1.30	0.14	0.43	0.29	0.58
b cell line:RPMI1788	10427-106D4	69.74	51.15	0.59	0.30	0.59	1.34	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	5.83	20.81	0.28	0.00	0.00	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	24.71	15.88	0.40	0.20	0.20	0.10	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	20.59	15.73	0.50	0.00	0.67	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	31.32	13.42	2.24	0.56	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	39.33	49.43	0.65	1.30	0.87	0.22	0.11
blood, adult, pool1	10053-101G8	28.79	11.07	4.43	4.43	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	6.85	42.82	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	37.12	43.86	10.80	7.42	2.70	0.67	2.70
brain, adult, donor1	10084-102B3	35.88	16.40	0.00	2.05	3.08	2.05	2.05
brain, adult, pool1	10012-101C3	33.85	14.25	0.89	1.11	0.45	0.33	0.33
brain, fetal, pool1	10085-102B4	53.43	10.69	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	49.55	13.21	4.29	1.65	0.33	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	48.18	112.96	1.12	0.37	0.50	1.62	0.37
breast, adult, donor1	10080-102A8	42.30	23.99	2.53	0.63	0.63	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.71	10.04	1.52	0.51	0.25	0.13	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	56.90	25.36	1.86	0.62	0.62	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	11.97	37.99	2.30	2.30	0.46	0.92	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	33.89	24.93	1.21	0.97	0.24	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	15.05	22.10	1.41	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	58.52	60.92	0.98	0.66	0.00	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	40.88	27.57	2.22	0.63	0.00	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.06	10.91	4.26	4.53	0.80	0.00	0.80
caudate nucleus - adult, donor10196	10177-103C6	26.48	27.63	0.00	1.15	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	41.50	18.57	1.34	1.84	0.00	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	22.92	10.70	0.00	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	18.68	8.79	2.93	0.73	1.46	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	99.05	113.62	5.83	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	114.23	127.47	4.06	3.20	1.49	0.21	0.64
cerebellum, adult, pool1	10083-102B2	32.77	27.94	1.03	1.72	0.34	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	77.22	92.99	9.13	2.49	2.49	0.83	0.00
cerebral meninges, adult	10188-103D8	19.16	9.58	1.51	0.00	1.26	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	24.85	15.35	1.46	0.73	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	30.05	12.22	0.43	0.14	0.72	0.43	0.00
cervical cancer cell line:ME-180	10553-107I4	27.01	51.54	0.33	0.00	0.00	0.66	0.17
cervix, adult, pool1	10013-101C4	44.62	64.88	0.84	0.63	1.47	0.52	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.90	5.99	0.98	0.14	0.14	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	20.90	11.76	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	57.91	24.73	1.74	1.12	2.98	0.12	0.62
choriocarcinoma cell line:SCH	10785-110H2	49.04	34.87	2.22	0.74	0.12	0.49	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	36.05	29.88	1.19	0.47	0.95	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	10.26	23.08	0.28	0.85	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	21.97	22.57	1.59	0.30	1.59	0.30	0.20
chorionic membrane cells, donor3	12240-129G8	13.74	29.12	2.75	2.20	2.20	0.55	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	9.09	6.06	3.03	1.01	0.00	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	33.62	18.06	0.77	0.19	0.19	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	34.85	10.14	0.84	0.42	0.21	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	47.76	39.55	3.60	1.54	0.51	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	49.59	42.33	3.39	2.18	0.24	0.00	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.14	38.08	2.65	1.83	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	32.68	32.10	1.18	0.59	0.29	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	38.05	21.63	0.52	0.00	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	23.77	15.54	5.03	2.29	0.91	0.00	1.14
clear cell carcinoma cell line:TEN	10636-108I6	33.14	7.29	1.04	0.52	0.69	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	35.88	18.67	0.37	0.00	0.00	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	113.26	57.39	1.52	0.76	0.76	0.00	0.00
colon, adult, donor1	10082-102B1	38.08	52.36	3.57	2.38	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	34.19	57.11	1.29	0.47	1.88	0.47	0.47
colon, fetal, donor1	10070-101I7	25.34	37.08	0.00	0.62	0.62	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	142.09	18.33	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	37.82	45.89	0.85	0.00	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.98	14.49	0.91	0.15	0.30	0.15	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	23.27	14.95	0.71	0.14	0.14	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	67.55	53.07	0.66	0.44	0.55	0.66	0.33
cruciate ligament, donor2	10295-104G7	47.82	49.44	3.24	2.43	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	28.09	21.67	0.00	1.61	0.00	0.00	0.00
diencephalon, adult	10193-103E4	20.88	11.28	0.72	0.72	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	70.26	9.87	10.10	5.97	2.76	0.23	2.98
ductal cell carcinoma cell line:KLM-1	10438-106E6	47.44	32.31	0.77	0.77	0.26	0.51	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	14.92	17.57	0.24	0.00	0.00	0.48	0.00
ductus deferens, adult	10196-103E7	58.31	29.90	4.98	6.48	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	21.60	2.88	2.88	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.93	39.73	5.89	6.62	2.94	0.00	2.21
dura mater, adult, donor1	10041-101F5	89.36	58.97	1.07	1.32	1.32	0.33	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	29.98	7.33	2.00	0.22	2.66	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	33.96	23.64	2.44	0.00	0.57	0.14	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	57.35	14.18	1.85	1.23	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	42.08	13.02	3.03	1.21	1.51	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	58.04	24.70	1.85	1.23	0.00	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	78.81	22.33	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	75.42	34.19	0.67	0.67	1.01	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	26.28	33.17	1.27	0.72	0.54	1.09	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	21.39	21.87	2.89	1.61	0.80	0.32	1.45
epidermoid carcinoma cell line:A431	10426-106D3	36.13	31.12	0.44	0.22	0.33	0.33	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	33.00	24.09	0.11	0.33	0.22	0.44	0.33
epididymis, adult	10197-103E8	44.58	35.79	5.65	0.84	2.51	0.00	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	18.63	34.95	1.06	0.35	0.18	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	28.71	17.30	0.79	0.00	0.39	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	40.63	17.56	1.97	1.31	0.52	0.52	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	37.10	9.94	1.57	0.89	0.10	0.20	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	35.96	13.56	2.58	1.34	0.34	0.11	0.34
esophagus, adult, pool1	10015-101C6	24.10	56.17	0.96	1.81	2.44	0.96	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	25.55	33.19	0.25	0.25	0.50	0.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	70.02	55.54	12.07	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	35.77	6.31	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	29.76	14.88	2.98	0.00	0.00	1.49	1.49
eye - muscle superior, donor2	10297-104G9	40.13	37.83	0.00	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	45.18	16.03	0.00	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	26.95	24.66	2.03	2.03	0.25	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	23.21	9.36	1.28	0.13	0.13	0.00	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	45.82	8.78	0.24	0.71	0.47	0.00	0.71
frontal lobe, adult, pool1	10040-101F4	52.64	17.64	0.56	0.00	0.19	0.38	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	45.64	27.62	2.70	0.60	0.90	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	52.94	38.40	1.01	0.46	0.27	0.18	0.18
gall bladder, adult	10198-103E9	45.87	38.39	2.41	1.21	2.17	0.72	0.00
gamma delta positive T cells, donor1	11937-126A2	68.18	40.80	1.61	0.54	0.54	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	48.93	35.11	2.61	1.49	1.49	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	40.76	19.22	5.28	2.53	0.84	0.00	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	40.81	27.85	1.16	0.58	0.19	0.19	0.39
gastric cancer cell line:AZ521	10549-107H9	60.99	34.43	1.15	0.16	0.16	0.49	0.16
gastric cancer cell line:GSS	10560-108A2	57.66	17.39	0.92	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	75.85	63.74	9.14	7.08	2.51	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	18.82	1.95	0.69	0.23	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	33.45	22.39	0.28	0.28	0.00	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	46.14	36.17	2.00	0.75	0.25	0.25	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	27.34	43.28	0.84	0.32	0.21	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	27.67	44.24	0.28	0.00	0.28	0.98	0.14
glioblastoma cell line:T98G	10485-107A8	16.56	26.49	0.66	0.22	0.33	0.33	0.11
glioma cell line:GI-1	10413-106B8	24.89	11.13	0.29	0.00	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	38.63	26.24	0.00	0.00	0.00	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	68.83	61.76	3.66	1.71	0.24	0.98	0.73
globus pallidus, adult, donor10258	10367-105F7	24.65	20.54	5.48	2.74	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	21.85	11.72	0.00	0.00	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	154.17	12.24	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	16.00	20.16	4.48	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	28.01	11.48	1.38	1.38	1.84	0.46	0.92
hIPS +CCl2, biol_rep2	14384-156C1	21.49	14.18	1.37	0.91	0.00	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	36.71	10.95	1.29	2.58	2.58	0.00	0.64
hIPS, biol_rep1	14380-156B6	4.31	2.87	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	22.63	5.49	0.69	2.06	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	6.62	17.66	2.21	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	29.02	14.94	0.86	0.00	0.57	0.00	0.00
heart - mitral valve, adult	10205-103F7	37.37	46.94	1.79	1.20	0.30	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	40.01	42.36	1.31	3.92	0.78	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	75.77	19.15	2.50	0.83	1.67	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	28.77	23.47	2.04	2.86	0.61	0.41	0.82
heart, adult, diseased, donor1	10051-101G6	22.99	25.55	3.41	1.28	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	20.47	13.34	0.23	0.23	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	54.93	45.69	0.72	0.72	0.31	0.62	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.12	18.82	0.00	0.00	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	38.05	8.32	0.00	1.19	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	52.71	15.91	2.65	1.77	0.33	0.00	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	53.16	18.33	2.55	3.52	0.36	0.24	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	57.50	18.19	2.83	2.02	0.40	0.10	0.40
hepatoma cell line:Li-7	10484-107A7	29.81	27.58	2.00	0.33	0.33	0.00	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	28.74	16.08	0.50	0.10	0.20	0.30	0.50
hippocampus - adult, donor10196	10169-103B7	47.32	10.41	0.95	0.95	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	65.11	32.66	3.67	2.65	1.02	0.41	1.43
hippocampus, adult, donor10258	10374-105G5	20.91	7.47	0.50	1.00	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	27.14	12.34	1.41	0.35	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	40.89	11.60	5.49	4.27	1.83	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	33.77	6.09	3.73	1.57	2.55	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.38	5.59	6.09	0.51	2.03	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	47.93	18.61	1.69	1.69	6.20	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	60.16	15.49	13.43	9.55	6.71	0.00	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	43.28	19.74	3.80	1.14	8.35	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	41.46	20.73	3.50	1.17	5.55	0.00	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	49.76	21.11	7.54	1.51	6.89	0.00	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	37.54	12.10	2.50	0.42	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	25.81	9.95	0.95	0.71	1.66	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	35.68	13.18	4.82	1.13	2.89	0.32	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	22.89	18.18	0.67	0.00	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	40.22	7.35	2.82	1.56	2.35	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	32.43	8.35	8.35	12.28	2.46	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	32.29	7.85	0.87	0.87	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	73.69	21.38	6.30	2.86	8.78	0.19	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	55.38	20.50	7.41	3.49	7.41	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	64.47	31.98	10.00	4.50	4.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	46.16	32.78	4.52	3.20	5.27	0.00	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	28.19	29.10	6.82	3.18	3.64	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.21	30.38	2.19	1.57	3.45	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	20.41	17.64	2.29	0.49	1.31	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	16.84	15.68	2.32	0.87	2.03	0.29	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	25.41	17.64	3.29	0.90	2.39	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	37.50	9.61	3.69	1.11	2.22	0.18	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	32.81	8.56	2.28	2.28	2.57	0.29	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	53.49	19.19	3.27	3.27	3.67	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	44.36	25.70	7.04	6.69	4.93	0.00	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	44.03	14.57	2.85	2.22	6.65	0.00	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	42.67	20.28	4.54	1.21	3.03	0.61	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	31.03	26.89	3.62	0.52	2.59	1.03	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	27.23	23.25	1.99	1.99	0.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	26.94	17.44	1.54	0.51	2.05	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.71	17.13	3.07	2.30	2.56	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	22.72	14.39	3.79	0.76	3.79	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.48	14.79	1.68	0.67	1.01	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	34.54	7.25	3.38	2.17	0.72	0.48	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	41.89	12.03	3.57	3.12	4.46	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	48.29	11.71	4.88	0.49	1.95	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	54.40	20.48	7.03	3.67	9.17	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	55.31	94.34	9.76	22.77	26.03	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	42.69	32.10	4.30	3.31	8.60	0.00	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	34.48	27.91	6.57	1.09	3.28	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	39.81	29.67	1.81	1.81	2.90	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.52	24.20	2.85	4.27	2.14	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	15.51	13.13	4.77	1.19	2.39	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	31.42	21.26	1.90	0.95	3.66	0.27	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	19.13	9.70	2.16	0.81	1.08	0.00	0.81
immature langerhans cells, donor1	11904-125F5	38.99	44.07	2.42	0.24	0.24	0.73	0.00
immature langerhans cells, donor2	11905-125F6	30.10	58.62	0.79	0.00	0.00	1.58	0.00
insula, adult, pool1	10039-101F3	65.68	23.94	0.57	0.57	0.28	0.19	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	15.93	14.31	0.65	0.65	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	28.74	31.24	1.10	0.50	0.80	0.10	0.40
kidney, fetal, pool1	10045-101F9	54.47	36.57	0.50	1.13	0.42	0.28	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	90.89	42.75	0.71	0.28	0.71	0.57	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	18.39	20.74	0.55	0.83	0.69	0.14	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	48.81	9.91	0.37	0.18	0.37	0.00	0.00
left atrium, adult, donor1	10079-102A7	17.98	10.35	1.09	0.00	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	16.18	8.60	0.00	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	18.88	14.23	0.27	0.27	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	3.23	10.78	2.16	1.08	1.08	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	4.35	14.67	1.09	0.00	0.54	0.54	0.54
leiomyoma cell line:15425	10571-108B4	5.58	13.84	1.46	0.97	0.24	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	37.64	21.96	4.18	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	27.51	29.51	0.94	0.24	0.24	0.35	0.59
liposarcoma cell line:KMLS-1	10782-110G8	17.81	21.71	0.94	0.00	0.47	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	29.97	26.07	0.85	0.49	0.12	0.24	0.12
liver, adult, pool1	10018-101C9	17.34	13.45	0.32	0.65	2.11	0.00	0.00
liver, fetal, pool1	10086-102B5	12.23	28.22	0.00	0.00	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	41.56	35.58	0.87	1.02	0.00	0.58	0.15
locus coeruleus, adult, donor10252	10165-103B3	34.70	41.52	1.85	1.48	0.37	0.74	0.37
locus coeruleus, adult, donor10258	10375-105G6	14.67	15.80	3.10	3.10	1.13	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	20.19	26.08	2.94	2.10	2.52	0.42	0.84
lung adenocarcinoma cell line:A549	10499-107C4	15.78	16.61	0.00	0.00	0.00	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	55.84	42.74	0.69	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	44.69	27.81	0.79	0.40	0.00	0.40	0.00
lung, adult, pool1	10019-101D1	55.40	57.29	2.13	0.47	2.48	0.35	0.12
lung, fetal, donor1	10068-101I5	45.38	126.15	3.14	0.86	4.00	2.28	1.43
lung, right lower lobe, adult, donor1	10075-102A3	38.95	27.95	1.83	1.37	3.21	0.46	1.37
lymph node, adult, donor1	10077-102A5	37.87	10.89	0.47	3.31	2.37	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	54.14	30.47	3.07	0.44	0.44	0.22	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	81.20	33.51	6.19	0.75	1.06	0.30	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	36.53	58.62	2.55	0.00	0.85	3.40	0.00
mature adipocyte, donor1	12231-129F8	19.98	16.87	0.89	0.00	0.89	0.44	0.00
mature adipocyte, donor2	12232-129F9	23.04	34.45	0.21	0.21	1.04	0.00	0.21
mature adipocyte, donor3	12233-129G1	18.49	27.26	0.24	0.24	0.95	0.24	0.00
mature adipocyte, donor4	12234-129G2	24.22	31.06	2.11	0.26	0.26	0.53	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	86.96	48.13	0.71	0.71	1.19	0.95	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	34.97	12.41	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	65.47	34.02	2.94	0.74	0.74	0.37	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	20.01	5.08	0.95	1.27	0.32	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	27.72	18.34	2.99	1.71	0.00	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	50.96	12.99	6.92	9.11	1.01	0.17	2.19
medial temporal gyrus, adult, donor10252	10156-103A3	71.31	39.47	2.12	2.33	0.64	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	3.85	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	21.18	8.61	1.44	1.08	0.36	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	25.31	29.20	0.00	0.65	0.00	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	46.75	51.86	1.86	0.93	1.08	0.31	0.46
medulla oblongata, adult, pool1	10038-101F2	44.32	50.12	0.33	0.41	0.16	0.73	0.33
medulla oblongata, newborn, donor10223	10361-105F1	28.12	15.28	2.08	0.00	1.04	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	56.90	23.03	4.65	3.54	1.11	0.22	1.11
medulloblastoma cell line:ONS-76	10759-110E3	23.11	14.43	0.00	0.12	0.12	0.37	0.12
melanoma cell line:COLO 679	10514-107E1	14.52	22.14	0.72	0.00	1.15	0.43	0.14
melanoma cell line:G-361	10465-106H6	30.68	16.56	0.81	0.54	0.27	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	12.66	18.63	3.26	1.27	0.00	0.18	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	66.09	27.32	4.41	1.76	2.64	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	51.84	24.89	4.15	1.30	0.52	0.78	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	9.82	8.75	0.31	0.31	0.15	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.09	11.27	0.36	0.36	0.36	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.14	13.25	0.00	0.00	0.00	0.00	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.16	11.94	0.14	0.28	0.14	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.05	10.01	0.19	0.58	0.19	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	21.52	2.08	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.64	7.04	0.51	0.51	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	9.20	13.23	0.69	0.81	0.23	0.46	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	6.90	8.22	0.00	0.40	0.13	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	9.18	10.53	0.14	0.41	0.14	0.00	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.51	15.65	0.85	0.85	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	22.73	12.19	1.32	0.00	0.00	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	13.42	14.11	0.28	0.42	0.00	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.12	17.80	1.05	0.35	0.70	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.35	13.47	0.41	0.20	0.00	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.58	23.01	1.80	0.00	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.97	13.86	0.10	0.31	0.21	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.70	19.15	1.14	0.23	0.46	1.37	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	7.55	26.43	0.00	0.00	0.84	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.71	10.91	0.30	0.45	0.15	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.34	13.22	0.18	0.53	0.35	0.44	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	11.78	19.14	0.00	0.37	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.88	25.47	2.86	0.29	0.57	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	5.89	5.89	1.26	0.42	1.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	2.74	11.87	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	2.81	14.84	0.00	0.26	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	3.66	14.13	0.26	0.52	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.09	18.79	0.31	0.00	0.62	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.65	14.36	0.24	0.47	0.24	0.00	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.12	23.35	1.02	0.00	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.29	9.82	0.00	0.39	0.00	1.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.02	12.51	0.46	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	4.90	14.71	0.58	0.58	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	4.02	13.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	5.53	16.10	0.24	0.00	0.00	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	14.67	14.67	2.20	0.73	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	4.36	9.40	0.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.50	16.38	0.82	0.41	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.87	9.45	0.00	0.00	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	16.41	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	1.95	7.15	0.32	0.32	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	14.55	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	3.20	6.40	2.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	2.45	11.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	4.66	6.61	0.39	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	18.89	4.20	2.10	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	10.93	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.93	11.86	0.59	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	2.44	7.31	1.22	0.00	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.33	13.30	0.00	0.00	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.45	10.00	0.69	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	6.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	11.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	6.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.93	8.96	0.41	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	4.77	12.71	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	15.33	0.00	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.68	12.78	0.62	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	4.01	10.69	0.00	2.67	0.00	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	15.37	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	7.70	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.20	12.39	0.00	2.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.86	11.88	0.00	0.00	0.49	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	11.22	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	15.90	1.27	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.51	13.30	0.81	0.81	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	17.44	4.36	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	13.94	1.27	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.71	8.50	1.21	1.21	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	9.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	13.18	8.24	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.96	14.49	0.60	0.00	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.89	9.09	0.32	0.65	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	17.32	1.02	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	49.52	55.71	0.77	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	55.99	39.45	0.71	0.71	0.24	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	31.51	54.44	1.39	0.23	0.00	1.85	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	12.82	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	21.89	30.21	1.03	0.41	0.41	0.41	0.10
mesothelioma cell line:Mero-25	10850-111F4	34.95	3.63	1.82	0.45	0.45	0.00	0.68
mesothelioma cell line:Mero-41	10851-111F5	26.40	19.56	1.71	0.24	0.24	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	12.62	23.69	0.44	0.89	0.00	0.44	0.66
mesothelioma cell line:Mero-82	10853-111F7	27.86	7.36	2.37	2.10	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	15.15	11.06	0.51	0.17	0.85	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	9.35	19.72	0.76	0.00	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	11.18	9.73	0.21	0.21	0.21	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	13.09	12.92	0.33	0.00	0.17	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	17.19	16.47	0.36	0.72	0.36	0.18	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	17.77	19.13	0.85	0.17	0.17	0.00	0.68
mesothelioma cell line:NCI-H28	10845-111E8	20.36	11.96	1.27	1.02	0.25	0.00	0.25
mesothelioma cell line:No36	10857-111G2	17.29	8.81	0.33	0.65	0.33	0.00	1.30
mesothelioma cell line:ONE58	10858-111G3	14.36	11.92	1.63	1.08	0.54	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	14.78	114.39	3.26	0.58	0.96	1.15	0.19
migratory langerhans cells, donor2	11902-125F3	6.11	102.82	0.73	0.24	0.85	0.98	0.61
migratory langerhans cells, donor3	11903-125F4	15.44	78.07	1.26	0.36	0.72	0.72	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	26.44	12.73	2.94	1.31	1.63	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.08	4.45	1.70	1.48	0.42	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	20.50	22.58	0.46	0.69	0.46	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	16.75	23.03	1.14	0.19	0.57	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	20.88	9.98	0.37	0.00	0.18	0.18	0.00
myeloma cell line:PCM6	10474-106I6	19.77	48.03	1.58	0.40	0.00	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	27.39	21.31	1.01	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	21.38	19.22	0.59	0.20	0.00	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	7.24	19.39	0.11	0.00	0.45	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.75	21.11	0.07	0.29	0.15	0.37	0.07
nasal epithelial cells, donor2	12227-129F4	9.94	23.74	0.55	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	87.19	50.61	1.38	0.23	0.46	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	55.38	37.98	0.56	0.37	0.56	0.75	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	105.87	22.35	3.80	2.74	0.63	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	67.65	9.50	1.30	0.56	0.19	0.00	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	64.76	7.59	8.78	3.80	1.19	0.00	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	80.77	24.07	7.29	3.64	2.22	0.48	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	20.93	3.02	0.40	0.40	0.00	0.00	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	70.57	17.80	0.64	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	11.18	19.16	0.53	0.27	0.00	0.27	0.27
neutrophil PMN, donor1	12133-128D9	44.62	29.75	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	79.68	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	75.77	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	127.52	14.04	2.71	0.51	0.68	0.17	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	37.62	42.43	0.00	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	10.26	12.18	0.32	0.64	0.00	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	20.23	25.49	5.26	0.53	0.26	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	47.43	21.65	0.28	0.84	0.09	0.28	0.28
occipital cortex - adult, donor10196	10172-103C1	67.99	22.66	0.00	2.06	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	92.59	49.11	2.68	1.61	0.27	0.00	1.07
occipital cortex, newborn, donor10223	10355-105E4	30.57	16.01	2.18	0.73	0.00	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	33.59	6.30	2.62	0.52	2.62	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	58.36	6.01	7.72	0.43	2.15	0.00	0.00
occipital pole, adult, pool1	10036-101E9	34.45	15.69	0.32	0.47	0.39	0.08	0.08
olfactory region, adult	10195-103E6	38.02	12.23	2.29	3.06	1.15	0.19	0.19
optic nerve, donor1	10277-104E7	40.02	42.02	2.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	33.49	20.62	0.57	0.11	0.57	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	26.65	13.88	0.14	0.27	0.00	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	27.09	23.20	9.99	2.88	1.69	0.17	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	45.97	17.10	1.16	1.04	0.69	0.00	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	15.58	22.34	0.29	0.29	0.29	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	104.65	28.96	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	21.42	36.05	0.42	0.00	1.06	1.06	0.00
ovary, adult, pool1	10020-101D2	31.88	40.09	0.70	0.61	2.10	0.44	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	32.81	18.88	0.73	0.73	0.18	0.00	0.00
pancreas, adult, donor1	10049-101G4	31.98	12.23	2.82	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	41.37	24.88	1.68	0.28	0.28	0.84	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	14.99	13.46	5.11	0.34	0.51	0.34	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	55.47	21.03	1.32	0.83	0.50	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	40.73	22.70	0.55	0.46	0.00	0.27	0.27
parietal cortex, adult, donor10258	10373-105G4	20.55	19.08	0.73	1.47	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	39.50	24.45	1.88	0.00	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	67.84	33.06	3.14	2.57	0.86	0.29	0.86
parietal lobe, adult, pool1	10034-101E7	47.94	23.44	0.35	0.35	0.35	0.44	0.18
parietal lobe, fetal, donor1	10072-101I9	77.59	11.64	7.76	1.94	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	32.15	17.57	2.24	1.87	0.37	0.37	0.00
parotid gland, adult	10199-103F1	29.60	8.02	1.23	0.00	1.23	0.00	0.00
penis, adult	10200-103F2	31.15	38.67	3.76	4.83	1.07	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	50.02	35.14	1.86	1.67	2.05	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	40.36	15.88	1.75	0.87	0.58	0.15	0.44
pineal gland - adult, donor10196	10179-103C8	67.08	72.24	2.58	1.29	1.29	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	90.02	135.62	1.18	2.37	2.37	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	47.03	56.44	0.63	1.25	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	96.12	87.01	7.08	4.05	5.06	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	124.04	124.56	3.13	1.56	1.04	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	57.03	68.10	3.40	1.70	1.70	1.70	1.70
placenta, adult, pool1	10021-101D3	36.44	56.44	1.18	1.40	0.86	0.65	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	46.08	36.55	2.91	0.93	0.66	0.40	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	32.68	34.40	1.56	0.16	0.78	0.31	0.16
pons, adult, pool1	10033-101E6	26.85	47.85	0.26	0.43	0.09	0.95	0.00
postcentral gyrus, adult, pool1	10032-101E5	37.83	15.08	0.26	0.70	0.44	0.26	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	94.11	8.37	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	37.87	18.21	2.04	0.44	0.00	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	30.86	27.77	1.09	0.36	0.54	0.18	0.18
prostate, adult, pool1	10022-101D4	33.47	33.83	0.45	0.73	1.00	0.27	0.18
putamen, adult, donor10196	10176-103C5	37.06	15.34	2.12	0.71	0.47	0.24	0.71
putamen, adult, donor10252	10152-102I8	17.65	29.41	3.92	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	5.46	1.09	1.09	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	21.50	10.87	0.97	0.48	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	16.49	40.48	4.50	2.25	2.25	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	39.86	27.35	0.29	0.29	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	65.38	19.47	1.39	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	16.11	40.07	1.06	0.21	0.21	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	56.75	73.73	4.14	0.83	1.24	0.00	0.83
retina, adult, pool1	10030-101E3	60.14	62.92	0.99	2.48	0.50	0.40	0.70
retinoblastoma cell line:Y79	10475-106I7	86.51	30.92	3.38	0.52	0.52	0.52	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	48.07	29.26	0.61	0.61	0.37	0.86	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	99.54	43.59	0.84	0.28	0.28	0.28	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.86	37.89	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	18.94	19.75	0.49	1.62	0.81	0.16	0.65
salivary acinar cells, donor2	11772-123I8	15.42	29.05	1.10	1.51	0.28	0.55	0.41
salivary acinar cells, donor3	11773-123I9	33.10	56.27	1.32	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	13.15	24.02	0.00	0.00	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.17	20.91	0.67	0.17	0.25	0.08	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	21.28	20.34	0.47	0.12	0.12	0.12	0.00
seminal vesicle, adult	10201-103F3	87.83	35.45	8.99	3.17	2.65	1.59	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	29.64	20.65	3.64	2.67	1.46	0.49	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.61	6.04	1.26	0.00	0.25	0.00	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	26.09	8.03	4.01	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	93.08	17.19	2.15	1.07	0.54	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	37.58	14.04	0.77	0.11	0.33	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	31.35	45.93	0.65	0.52	0.39	0.52	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	49.65	26.25	1.42	0.71	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	38.98	25.07	0.36	0.72	2.28	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	20.10	4.02	2.01	0.00	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	6.79	40.71	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	26.51	26.51	2.52	0.63	1.26	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	54.03	28.68	0.33	0.67	0.67	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	38.77	29.94	6.30	3.15	0.32	0.32	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	69.39	32.38	3.47	1.93	1.93	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	74.01	19.78	0.49	0.33	0.66	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	135.92	83.00	6.59	2.57	2.41	0.48	1.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	91.31	48.81	3.05	1.31	0.65	0.44	0.65
small intestine, adult, pool1	10024-101D6	36.19	82.54	0.36	1.43	1.79	0.60	0.36
small intestine, fetal, donor1	10064-101I1	33.41	16.46	2.46	3.69	0.74	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	44.62	63.09	13.34	8.21	0.00	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	27.40	32.05	1.29	1.81	0.78	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	59.50	33.23	0.54	0.27	0.00	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	49.09	34.41	4.36	5.05	0.69	0.23	0.69
spinal cord, adult, donor10252	10159-103A6	42.58	54.02	1.97	1.58	0.79	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	20.75	38.05	0.69	3.46	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	29.88	20.73	6.71	0.61	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	29.85	34.44	2.30	0.92	1.84	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	10.75	16.58	0.45	0.30	0.00	0.30	0.00
spleen, adult, pool1	10025-101D7	59.36	37.78	0.44	0.88	1.76	0.33	0.22
spleen, fetal, pool1	10044-101F8	58.88	72.70	0.72	1.19	0.32	0.32	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	35.30	43.79	1.04	0.21	0.31	0.62	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.79	49.18	0.57	0.57	0.19	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	35.29	34.95	5.94	3.15	0.70	1.05	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	32.45	25.41	3.52	1.56	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	31.52	36.13	0.79	0.45	0.34	0.11	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	17.79	24.15	0.42	0.85	0.85	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	32.58	10.15	0.00	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	75.83	30.97	4.27	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	42.16	20.51	8.55	1.14	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	42.16	58.78	3.74	1.66	1.04	0.83	0.62
substantia nigra, adult, donor10258	10371-105G2	13.45	15.00	0.52	0.00	0.52	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	25.44	17.66	0.71	2.12	0.71	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	45.39	44.94	1.38	0.00	0.69	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	46.79	15.68	0.42	0.93	0.34	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	67.67	7.83	7.12	0.00	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	39.56	8.35	10.55	0.88	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	10.82	13.61	4.19	1.40	0.70	0.00	0.00
tenocyte, donor2	11765-123I1	9.92	7.25	0.38	1.91	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	7.04	9.64	1.11	0.00	1.11	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	53.71	14.79	1.87	0.85	0.17	0.17	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	46.40	19.73	2.62	1.08	1.23	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	43.08	5.58	0.62	0.77	0.31	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	59.03	13.96	2.16	0.38	0.76	0.63	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	81.69	17.77	0.76	0.76	0.38	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	47.99	14.18	1.20	1.31	1.31	0.44	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	88.27	15.63	12.38	15.31	3.91	0.33	2.61
testis, adult, pool1	10026-101D8	65.71	36.72	2.90	3.22	6.12	0.21	0.64
testis, adult, pool2	10096-102C6	115.93	41.05	18.04	7.22	4.06	0.00	3.16
thalamus - adult, donor10196	10168-103B6	32.02	38.64	0.00	0.00	3.31	0.00	1.10
thalamus, adult, donor10252	10154-103A1	57.82	55.48	3.75	0.78	0.78	0.16	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	40.03	1.54	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.82	14.16	1.98	1.48	0.16	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	11.51	11.51	1.73	1.15	0.58	0.58	0.58
throat, adult	10209-103G2	34.95	46.69	6.74	1.00	1.25	0.25	0.50
throat, fetal, donor1	10061-101H7	26.20	16.15	3.96	0.91	0.91	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	67.17	7.35	2.19	0.60	0.20	0.00	0.40
thymus, adult, pool1	10027-101D9	32.31	136.50	1.99	1.09	4.27	2.78	0.70
thymus, fetal, pool1	10043-101F7	57.36	242.41	1.66	1.45	1.56	3.74	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	26.33	23.67	0.80	0.66	0.53	0.13	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	19.00	6.98	0.56	0.28	0.42	0.00	0.14
thyroid, adult, pool1	10028-101E1	34.62	18.57	0.93	0.75	1.03	0.19	0.37
thyroid, fetal, donor1	10060-101H6	35.33	18.19	1.32	3.43	0.26	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	58.51	3.08	0.00	3.08	3.08	0.00
tongue, adult	10203-103F5	23.72	36.75	3.72	2.56	1.63	0.23	0.70
tongue, fetal, donor1	10059-101H5	18.13	19.31	1.58	1.18	1.58	0.00	1.18
tonsil, adult, pool1	10047-101G2	64.51	65.21	0.40	0.60	0.60	0.30	0.10
trachea, adult, pool1	10029-101E2	35.34	29.77	0.57	0.90	1.39	0.25	0.08
trachea, fetal, donor1	10058-101H4	22.31	21.16	1.15	2.31	0.77	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.46	18.78	0.71	0.00	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	30.80	5.98	0.81	0.10	0.41	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	53.12	11.75	1.88	0.94	2.66	0.00	0.31
tridermal teratoma cell line:HGRT	10694-109G1	20.93	20.93	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	63.91	34.62	1.10	0.17	0.76	0.25	0.25
umbilical cord, fetal, donor1	10057-101H3	20.87	18.78	2.09	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	24.57	62.11	0.68	1.54	0.34	0.17	0.68
uterus, fetal, donor1	10055-101H1	19.97	20.99	0.00	2.56	0.00	0.00	0.00
vagina, adult	10204-103F6	40.06	53.63	0.65	1.29	0.00	0.65	0.00
vein, adult	10191-103E2	40.33	37.92	4.60	1.10	1.97	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.16	29.11	1.60	0.53	0.27	0.00	0.80